stockrowElanco Animal Health Incorporated
ELAN Healthcare Drug Manufacturers Specialty & Generic
Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.
- Revenue
- +10.2%
- EPS
- +450.0%
- Free cash flow
- +35.6%
- Total debt
- −6.91%
Quarter to June 2026, against a year earlier
Follow ELAN
Alert me
Elanco Animal Health Incorporated (ELAN) Operating margin
Elanco Animal Health Incorporated's operating margin over the twelve months to 30 June 2026 was 1.61%, up 1.3 percentage points from fiscal 2025 (0.32%). Over the past ten years it has ranged from −21.6% (fiscal 2020) to 6.03% (fiscal 2018); the current reading is higher than 64% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 0.32% | (1.96) |
| FY2024 | 2.28% | 21.37 |
| FY2023 | −19.1% | (23.65) |
| FY2022 | 4.56% | 11.49 |
| FY2021 | −6.93% | 14.62 |
| FY2020 | −21.6% | (27.57) |
| FY2019 | 6.02% | (0.01) |
| FY2018 | 6.03% | 14.08 |
| FY2017 | −8.05% | (7.19) |
| FY2016 | −0.86% | 8.01 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 7.97% | (3.19) |
| Mar 2026 | 11.2% | 27.16 |
| Dec 2025 | −16.0% | (16.18) |
| Sep 2025 | 0.18% | (6.59) |
| 31 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 24.0% |
| LNTH Lantheus Holdings, Inc. compare | 18.6% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 15.0% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 13.8% |
| RDY Dr. Reddy's Laboratories Ltd compare | 9.20% |
| ALKS Alkermes plc compare | 3.66% |
| ELAN Elanco Animal Health Incorporated | 1.61% |
| VTRS Viatris Inc. compare | −0.03% |
| HIMS Hims & Hers Health, Inc. compare | −5.99% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ELAN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement